Proteinase 3 Antibody Test

Proteinase 3 antibody is an autoantibody that targets proteinase 3, an enzyme stored within neutrophils. Neutrophils are white blood cells that act as the first responders of the immune system. In healthy physiology, proteinase 3 helps neutrophils break down microbes during an infection. When the immune system creates antibodies against this enzyme, it can mistake normal tissues for a threat. This process is called autoimmunity, which refers to an immune response directed against the body itself.

PR3 ANCA is strongly associated with granulomatosis with polyangiitis, a form of ANCA associated vasculitis. Vasculitis refers to inflammation of blood vessels. In this condition, the immune system becomes activated in a way that causes neutrophils to adhere to vessel walls, release enzymes, and damage small vessels throughout the body. Tissues with very fine vascular networks such as the sinuses, lungs, and kidneys are particularly vulnerable. This explains why symptoms often begin with chronic sinus disease or nosebleeds, persistent cough, or blood in the urine.

When PR3 ANCA binds to proteinase 3 on the surface of primed neutrophils, it can amplify inflammation by activating these cells. Activated neutrophils release toxic molecules that injure the lining of small vessels. This sequence is central to the pathophysiology of granulomatosis with polyangiitis. That said, the presence of this antibody alone does not create disease in every person. Antibody levels can fluctuate and sometimes rise without causing symptoms. Conversely, a person can have active vasculitis with low or even normal antibody levels. Clinicians therefore interpret PR3 ANCA in the context of symptoms and other test results.

High levels of PR3 ANCA increase the likelihood of granulomatosis with polyangiitis whereas low or absent levels lower this likelihood but do not eliminate it. PR3 ANCA is far less common in microscopic polyangiitis which is more often associated with a different autoantibody called MPO ANCA. Rarely, PR3 ANCA can appear in people with infections, inflammatory bowel disease, or in individuals taking certain medications. These results do not necessarily indicate vasculitis and usually require clinical correlation to determine significance.

Because antibody levels sometimes rise months before a clinical flare, PR3 ANCA can offer early clues of relapse in someone with known disease. Still, the correlation is imperfect. Rising titers may not always produce symptoms, and stable titers do not guarantee remission. For this reason PR3 ANCA is considered a supportive biomarker rather than a standalone tool for monitoring disease activity.

Overall, PR3 ANCA provides insight into abnormal immune activation in small vessel vasculitis. It is most helpful for diagnosing granulomatosis with polyangiitis, understanding the biologic driver of inflammation, and guiding long term follow up when interpreted together with symptoms, imaging, and kidney or lung tests.